The study defines cancer microbiome as the aggregate of microorganisms living in or on the human body along with their genomes that are influencing cancer manifestation and progression. Cancer microbiome sequencing has increasingly become an area of interest for the research community, which has the potential to revolutionize cancer care, largely due to studies that have significantly correlated the microbiome’s involvement in cancer manifestation.
This study aims at deciphering the potential of the cancer microbiome sequencing and its larger role in bolstering the current era of precision medicine.
As per BIS Research analysis, the global cancer microbiome sequencing market is projected to reach $1,216.2 Million by 2031 from $155.5 Million in 2020, at a CAGR of 20.01% during the forecast period of 2021-2031. Growth in this market is expected to be driven by the increasing emphasis on the microbiome’s potential in the field of cancer, global increase in cancer prevalence, and decreasing cost of sequencing. However, there are significant challenges that are restraining the market growth, such as the regulatory challenges for direct-to-consumer (DTC) companies, lack of high complexity testing centers, and existing diagnostic confidence in conventional cancer diagnostics.
The BIS Research report on the global cancer
microbiome sequencing market segments the market on the basis of:
§ offering (products and services)
§ application
(translational research and diagnostics)
§ technology (next
generation sequencing and polymerase chain reaction)
§ end use (academic and
research institutes, pharmaceutical and biotechnology companies, hospitals and
diagnostic laboratories, and other end users)
§ region (North America,
Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
Key Questions Answered in the Report
- How is cancer microbiome sequencing revolutionizing the field of oncology?
- What are the major market drivers, challenges, and opportunities in the global cancer microbiome sequencing market?
- What are the underlying structures resulting in the emerging trends within the global cancer microbiome sequencing market?
- How did the COVID-19 pandemic impact the global cancer microbiome sequencing ecosystem?
- What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
- What are the key regulatory implications in developed and developing regions pertaining to the use of cancer microbiome sequencing?
- What are the potential entry barriers, which are expected to be faced by the companies willing to enter a particular region?
- How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
o
Offering (product and service)
o
Application (translational research and diagnostics)
o
Technology (next-generation sequencing and
polymerase chain reaction)
o
End user (academic and research institutes,
pharmaceutical and biotechnology companies, hospitals and diagnostic
laboratories, and other end users)
o
Region (North America, Europe, Asia-Pacific,
Latin America, and Rest-of-the-World)
- What are the growth opportunities for the cancer microbiome sequencing companies in the region of their operation?
- Who are the leading players with significant offerings in the global cancer Which companies are anticipated to be highly disruptive in the future, and why?
Impact of COVID-19 on the Global Cancer Microbiome Sequencing
Market
The current global cancer microbiome
sequencing market study comprises products and services that are utilized to
analyze microbiome-associated biomarkers for cancer screening. Since the market
is primarily dominated by translational research, the COVID-19 pandemic had a high
impact on the growth or revenue generated from the market. The market
assessment has considered information given by key opinion leaders in the
market from both supply and demand sides. Manufacturers have witnessed
low-scale losses due to decreased demand, however, the losses incurred for the
first two-quarters of FY2020-2021 are anticipated to be compensated by higher
demands in the following two quarters. However, the industry is still expected
to be impacted significantly during the period 2020-2023.
Request a Sample - https://bisresearch.com/requestsample?id=1204&type=download
Comments
Post a Comment